These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 8847213)
1. Gene therapy for head and neck cancer. Clayman GL Head Neck; 1995; 17(6):535-41. PubMed ID: 8847213 [TBL] [Abstract][Full Text] [Related]
2. Gene therapy for head and neck cancer. Breau RL; Clayman GL Curr Opin Oncol; 1996 May; 8(3):227-31. PubMed ID: 8804819 [TBL] [Abstract][Full Text] [Related]
3. Department of Health and Human Services. Recombinant DNA Advisory Committee. National Institutes of Health. Minutes of Meeting. June 14, 1999. Hum Gene Ther; 2000 Jun; 11(9):1369-82. PubMed ID: 11032449 [No Abstract] [Full Text] [Related]
4. Recombinant DNA Advisory Committee. Department of Health and Human Services. National Institutes of Health. Minutes of meeting. December 15-16, 1997. Hum Gene Ther; 1998 Jul; 9(11):1643-95. PubMed ID: 9694162 [No Abstract] [Full Text] [Related]
5. Assessment of adenoviral vector safety and toxicity: report of the National Institutes of Health Recombinant DNA Advisory Committee. Hum Gene Ther; 2002 Jan; 13(1):3-13. PubMed ID: 11779411 [No Abstract] [Full Text] [Related]
6. NIH Recombinant DNA Advisory Committee data management report. March 12, 1999. Hum Gene Ther; 1999 Jun; 10(9):1577-89. PubMed ID: 10395382 [No Abstract] [Full Text] [Related]
7. Somatic gene therapy. Methods for the present and future. O'Malley BW; Ledley FD Arch Otolaryngol Head Neck Surg; 1993 Oct; 119(10):1100-7. PubMed ID: 8398061 [TBL] [Abstract][Full Text] [Related]
8. Gene therapy for head and neck cancer. Abuzeid WM; Li D; O'Malley BW Adv Otorhinolaryngol; 2011; 70():141-151. PubMed ID: 21358197 [TBL] [Abstract][Full Text] [Related]
9. NIH Recombinant DNA Advisory Committee data management report. June 18-19, 1998. Hum Gene Ther; 1998 Sep; 9(14):2143-61. PubMed ID: 9759940 [No Abstract] [Full Text] [Related]
10. The evolution of public review and oversight mechanisms in human gene transfer research: joint roles of the FDA and NIH. Friedmann T; Noguchi P; Mickelson C Curr Opin Biotechnol; 2001 Jun; 12(3):304-7. PubMed ID: 11404110 [TBL] [Abstract][Full Text] [Related]
11. Gene therapy principles and strategies for head and neck cancer. O'Malley BW; Couch ME Adv Otorhinolaryngol; 2000; 56():279-88. PubMed ID: 10868246 [TBL] [Abstract][Full Text] [Related]
12. Potential risk of inadvertent germ-line gene transmission statement from the American Society of Gene Therapy to the NIH Recombinant DNA Advisory Committee, March 12, 1999. Wilson JM; Wivel NA Hum Gene Ther; 1999 Jun; 10(9):1593-5. PubMed ID: 10395383 [No Abstract] [Full Text] [Related]
14. The National Institutes of Health Oversight of Human Gene Transfer Research: Enhancing Science and Safety. O'Reilly M; Jambou R; Rosenthal E; Montgomery M; Hassani M; Gargiulo L; Corrigan-Curay J Adv Exp Med Biol; 2015; 871():31-47. PubMed ID: 26374211 [TBL] [Abstract][Full Text] [Related]
15. Gene transfer for neurologic disease: agencies, policies, and process. Mendell JR; Miller A Neurology; 2004 Dec; 63(12):2225-32. PubMed ID: 15623678 [TBL] [Abstract][Full Text] [Related]
16. The new RAC: restructuring of the National Institutes of Health recombinant DNA Advisory Committee. Beach JE Food Drug Law J; 1999; 54(1):49-53. PubMed ID: 11758560 [No Abstract] [Full Text] [Related]
17. Department of Health and Human Services. National Institutes of Health. Recombinant DNA Advisory Committee. Minutes of meeting. March 6-7, 1997. Hum Gene Ther; 1997 Nov; 8(16):1955-2004. PubMed ID: 9382961 [No Abstract] [Full Text] [Related]
18. National Institutes of Health Recombinant DNA Advisory Committee (RAC). 91st meeting of the NIH RAC, Bethesda Marriott Hotel, Bethesda, Maryland, June 18-19, 20003. National Institutes of Health Recombinant DNA Advisory Committee Hum Gene Ther; 2003 Sep; 14(14):1361-5. PubMed ID: 14552317 [No Abstract] [Full Text] [Related]